Genmab A/S Stock

Genmab A/S Goodwill/Assets

The Goodwill to Total Assets Ratio of Genmab A/S (GMAB.CO) as of Aug 7, 2026 is 2.76 %. In the previous year, Goodwill to Total Assets Ratio was 5.53 % — a change of -50.16% (lower).

Goodwill/Assets

2.76 %

YoY

-50.16%

Last updated:

Goodwill to Total Assets Ratio of Genmab A/S is 2026 2.76 % . Goodwill to Total Assets Ratio of Genmab A/S was 2025 5.53 % . It decreases by -50.16% lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Goodwill to Total Assets Ratio of Genmab A/S is 2.76 % in 2026.

Goodwill to Total Assets Ratio of Genmab A/S changed from 5.53 % to 2.76 %, representing a -50.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill to Total Assets Ratio Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

The Goodwill/Assets ratio shows what percentage of total assets consists of acquisition goodwill. High ratios may indicate impairment risk.

Goodwill to Total Assets Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill to Total Assets Ratio's Genmab A/S historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Genmab A/S

All Key Metrics — Genmab A/S